Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (941)	3/6/1998 12:26:00 AM
From: luis a. garcia	Respond to of 1115

I thought so John... much is been made of this... luis

To: John Zwiener who wrote (941)	3/6/1998 10:53:00 AM
From: Henry Volquardsen	Read Replies (2) \| Respond to of 1115

John, with all due respect, stating that the directors own almost 1,000,000 shares is very misleading. The most recent filing I have seen shows that all insiders own 924,103 class A shares. Of that number Dr Katz owns 888,703 or 95.5% of the above number. The only other insiders who own any shares directly are Kenneth Olson who owns 36,400 class A shares and Timothy Russell (who I believe is not a director) owns 5,000 class A shares. Neither the new Chairman or President, as of yet, own a single share. The issue has not been what the ownership stake of the whole board has been but the ownership my board members other than Dr. Katz. That appears to be one man owning 36,400. Frankly I consider that abysmal.